Can Diabetes Cause Weight Gain? The Science Explained

Diabetes can absolutely cause weight gain, and the pathways involved go well beyond simply eating too much. Insulin, whether your body overproduces it or you inject it as treatment, is a powerful signal to store energy as fat. That hormonal reality, layered on top of medication side effects and behavioral patterns unique to managing blood sugar, means many people with diabetes find themselves gaining weight even when they feel like they are doing everything right. The relationship between diabetes and body weight is tangled enough that it deserves a closer look.

How Insulin Promotes Fat Storage

Insulin’s primary job is shuttling glucose out of the bloodstream and into cells. But it also acts as a storage hormone. When insulin levels are high, the body is in “store energy” mode, directing calories toward fat tissue rather than burning them. One model of how this works, sometimes called the carbohydrate-insulin model, proposes that diets heavy in processed, high-glycemic carbohydrates trigger hormonal shifts that push calories into fat cells, ramp up hunger, and lower the amount of energy you burn at rest.1Europe PMC. The Carbohydrate-Insulin Model of Obesity: Beyond “Calories In, Calories Out” That cycle is relevant to anyone eating a modern diet, but it hits harder for people with diabetes-related insulin problems.

In type 2 diabetes, the body becomes resistant to insulin’s glucose-clearing signal, so the pancreas compensates by pumping out more. This excess insulin still works as a fat-storage signal even while failing at its blood-sugar job. The result is a frustrating paradox: blood sugar stays high and fat accumulates simultaneously. Visceral fat, the deep belly fat packed around organs, is particularly tied to this process. That visceral fat then worsens insulin resistance through inflammation and disrupted signaling in the liver and muscles, creating a feedback loop that makes both the diabetes and the weight gain harder to control.2Europe PMC / Current Opinion in Endocrinology, Diabetes and Obesity. What causes the insulin resistance underlying obesity?

In type 1 diabetes, the situation is different but the outcome can be similar. Before diagnosis, people with type 1 often lose weight rapidly because without insulin, glucose passes straight through the kidneys and out in urine. Once insulin therapy begins, the body suddenly starts using and storing that glucose again. The weight that returns is partly healthy recovery, but the rebound can overshoot, especially if calorie intake stays at pre-treatment levels while insulin now makes those calories available for storage.

Diabetes Medications That Promote Weight Gain

Injected insulin is one of the most effective treatments for both type 1 and type 2 diabetes, but its weight effects are a well-documented trade-off. Weight gain from insulin therapy can stem from several overlapping causes: glucose that used to spill into urine is now retained and stored, people may eat more to prevent or recover from low blood sugar episodes, and the way injected insulin enters the body does not perfectly mimic natural pancreatic release.3PubMed. Insulin-associated weight gain in diabetes–causes, effects and coping strategies The concern about gaining weight on insulin is so widespread that it frequently delays treatment. Clinicians sometimes hold off on starting insulin in type 2 diabetes specifically because of the weight issue, even when blood sugar control demands it.4Europe PMC. Insulin therapy and type 2 diabetes: management of weight gain

Insulin is not the only culprit. Several oral diabetes medications carry their own weight-gain risks:

The net effect is that a substantial share of the medications traditionally used to manage diabetes push weight in the wrong direction. This creates a genuine clinical dilemma: better blood sugar control versus greater weight, each with its own set of long-term health consequences.

The Fear-of-Hypoglycemia Eating Cycle

One of the less obvious drivers of weight gain in diabetes is behavioral. People on insulin or sulfonylureas live with the constant risk of blood sugar dropping too low, known as hypoglycemia. The symptoms, which include shakiness, dizziness, confusion, and anxiety, are unpleasant at best and dangerous at worst. Over time, many people develop a fear of these episodes that subtly reshapes how they eat.

That fear can trigger what researchers describe as “defensive eating,” consuming extra carbohydrates as a precaution even when blood sugar is not actually low. In some people, the experience of treating a real or perceived low triggers a loss of dietary control. Sugary foods that someone normally restricts become permissible in the moment, and what starts as treating a low can cascade into overeating.9PubMed Central. Fear of Hypoglycemia and Disordered Eating Behavior in Type 1 Diabetes – Section: Discussion Fear of hypoglycemia can also reduce physical activity, because exercise lowers blood sugar and raises the perceived risk of a dangerous low. In type 1 diabetes specifically, the combination of intensive insulin therapy, defensive carbohydrate intake, and reduced activity driven by hypoglycemia fears is recognized as a major contributor to obesity.10PubMed Central. Obesity in Adults with Type 1 Diabetes Mellitus

This is not a willpower problem. It is a rational response to a genuinely dangerous symptom, shaped by anxiety and reinforced by repeated experience. But the extra calories add up, and the resulting weight gain further worsens insulin resistance in people with type 2 diabetes, tightening the feedback loop.

Newer Medications That Push Weight the Other Way

Not every diabetes drug leads to weight gain. Two newer classes of medication, GLP-1 receptor agonists and SGLT2 inhibitors, actually help people lose weight while improving blood sugar control. The most dramatic results come from higher-dose semaglutide, a GLP-1 receptor agonist, which in a systematic review and network meta-analysis showed an average body weight reduction of about 11.5 kilograms compared to placebo, alongside meaningful drops in blood sugar.11PubMed Central. Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis – Section: RESULTS

SGLT2 inhibitors work differently, causing the kidneys to excrete excess glucose in urine rather than reabsorbing it. Their weight-loss effect is more modest. In a head-to-head study of people with type 2 diabetes and obesity, participants on SGLT2 inhibitors lost about 2 kilograms over a year, compared to roughly 5.7 kilograms with semaglutide at a lower dose.12PubMed. Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity The availability of these weight-favorable options has started to reshape how clinicians approach type 2 diabetes treatment, particularly for people who are already struggling with weight. Strategies to reduce insulin-related weight gain also include lifestyle interventions focused on nutrition and physical activity, as well as using specific insulin formulations and insulin-sensitizing agents designed to minimize the fat-storage side effect.13The Endocrinologist. Consequences of Weight Gain Associated With Insulin Therapy in Adolescents

Leptin Resistance and Broken Appetite Signals

Beyond insulin, diabetes disrupts other hormones that help regulate body weight. Leptin is produced by fat cells and normally tells the brain that energy stores are adequate, suppressing appetite and keeping eating in check. In many people with obesity and type 2 diabetes, leptin levels are actually very high, but the brain stops responding to the signal. This is called leptin resistance, and it means the body behaves as if it is starving even when fat stores are abundant.14Europe PMC. Leptin signaling and leptin resistance The result is persistent hunger and a metabolic rate that does not ramp up the way it should in response to excess energy. Leptin resistance and insulin resistance often coexist and reinforce each other, making it harder to break out of the weight-gain cycle through dietary changes alone.

Conditions That Travel with Diabetes

Diabetes rarely travels alone, and several of its common companion conditions independently promote weight gain. Two of the most relevant are thyroid dysfunction and polycystic ovary syndrome (PCOS).

Hypothyroidism, where the thyroid gland produces too little hormone, is more common in people with diabetes than in the general population. Thyroid hormones influence appetite, energy expenditure, and insulin sensitivity through shared metabolic pathways.15PubMed. The interface between thyroid and diabetes mellitus When thyroid function dips, metabolic rate slows, and weight tends to creep up. Because the symptoms of hypothyroidism, including fatigue and weight gain, overlap with poorly controlled diabetes, the thyroid component can go unrecognized for a long time.

PCOS affects a significant number of women with insulin resistance. The relationship is bidirectional: weight gain worsens insulin resistance, which in turn drives the compensatory overproduction of insulin that disrupts ovarian function and boosts androgen levels.16Clinical Medicine. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance Insulin signaling in the brain also plays a role in ovulation and body weight regulation, meaning the metabolic and reproductive disruptions of PCOS are wired together at a deep level.17Endocrine Reviews. Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications For women managing both diabetes and PCOS, weight gain has multiple reinforcing drivers that a simple calorie-counting approach will not adequately address.

When the Scale Lies: Fluid Retention Versus Fat

Not all weight gain in diabetes is fat. Insulin has an effect on the kidneys that many people are unaware of: it promotes sodium retention, which causes the body to hold onto fluid. In people with poorly controlled diabetes who start or intensify insulin therapy, the shift can be dramatic enough to cause visible swelling, a condition known as insulin edema. The mechanism involves increased sodium reabsorption in the kidney tubules, sometimes amplified by transient spikes in aldosterone and the lingering effects of high blood sugar on fluid balance.18PubMed Central. Insulin-Induced Edema in a Patient with Type 2 Diabetes Mellitus – Section: Discussion

Insulin edema is typically temporary, resolving within days to weeks as the body adjusts. But it can add several pounds to the scale virtually overnight, which is demoralizing for someone who just started a new treatment and is already worried about weight. Recognizing this as fluid rather than fat can make a real psychological difference. If you notice rapid weight gain with swelling in the legs or around the ankles shortly after starting or increasing insulin, it is worth discussing with your doctor rather than assuming the treatment is making you fat.

Sleep, Gut Health, and Metabolic Feedback

Two areas of emerging research add layers to the diabetes-weight connection. Poor sleep and disrupted circadian rhythms, both common in people with diabetes, contribute to metabolic problems that promote weight gain. Sleep deficiency can alter when and how much you eat, impair glucose tolerance, reduce insulin sensitivity, and shift energy balance toward fat storage.19Europe PMC / Current Diabetes Reports. Metabolic consequences of sleep and circadian disorders If you are managing diabetes and also dealing with shift work, sleep apnea, or chronic insomnia, the metabolic deck is stacked even further against you.

The gut microbiome is another piece of the puzzle. People with diabetes consistently show imbalances in their intestinal bacteria, a state called dysbiosis, which is linked to reduced insulin sensitivity and poor blood sugar control.20Europe PMC / Cureus. Understanding the Role of the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review A disrupted microbiome promotes low-grade inflammation that further worsens insulin resistance. Research into whether targeting the microbiome through diet, prebiotics, or probiotics can meaningfully improve weight and blood sugar outcomes is still in its early stages, but the connection itself is well established enough to suggest that gut health is part of the broader metabolic picture for people with diabetes.

Diabulimia and the Dangerous Temptation of Insulin Restriction

The weight gain that accompanies insulin therapy creates a dark side effect: some people with type 1 diabetes deliberately skip or reduce their insulin doses to lose weight. This practice, informally called diabulimia, exploits the fact that without adequate insulin, the body cannot use glucose and begins burning fat and muscle instead. Blood sugar skyrockets, but weight drops.

The health consequences are severe. Chronic insulin restriction leads to diabetic ketoacidosis, nerve damage, kidney disease, and vision loss. People who engage in it report not just weight-control motivations but a complicated web of distress, shame, and a feeling of lost control that extends well beyond body image.21PubMed. Insulin restriction or omission in Type 1 Diabetes Mellitus: a meta-synthesis of individuals’ experiences of diabulimia The circumstances of living with diabetes, including the constant focus on food, the association of insulin with weight gain, and the visibility of body changes after diagnosis, can feed into disordered eating patterns in ways that are distinct from eating disorders in the general population.22PubMed. Disordered eating and insulin restriction in type 1 diabetes: A systematic review and testable model

Diabulimia is underdiagnosed partly because healthcare providers do not always screen for it and partly because patients are reluctant to disclose it. If you or someone you know is reducing insulin to control weight, it is one of the most medically dangerous forms of disordered eating and warrants urgent professional help.

The Evolutionary Angle

One way to understand why diabetes and weight gain are so tightly linked is to look at the problem through an evolutionary lens. The thrifty genotype hypothesis, first proposed in 1962, suggests that human populations spent most of their history cycling between feast and famine. Individuals whose metabolism was efficient at storing energy as fat during times of plenty had a survival advantage.23PubMed. Overview of the thrifty genotype hypothesis That metabolic thriftiness, according to the hypothesis, is now maladaptive in an environment of constant food availability.24PubMed Central. Metabolic thrift and the genetic basis of human obesity

The proposed metabolic basis of this “thrifty” heritage centers on selective insulin resistance, where insulin’s ability to clear glucose is impaired but its fat-storage signaling remains intact, leading to compensatory overproduction of insulin and an exaggerated drive to deposit fat.25PubMed. Relation Between Obesity and Type 2 Diabetes: Evolutionary Insights, Perspectives and Controversies This pattern describes almost exactly what happens in type 2 diabetes: the body resists insulin for glucose management but remains sensitive to its fat-promoting effects. The thrifty genotype idea remains debated and is probably too simple on its own to explain a condition as complex as diabetes, but it does offer a useful framework for understanding why the human body seems almost designed to gain weight when insulin levels rise in the context of abundant food.